443 related articles for article (PubMed ID: 16678109)
1. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
Gery S; Komatsu N; Baldjyan L; Yu A; Koo D; Koeffler HP
Mol Cell; 2006 May; 22(3):375-82. PubMed ID: 16678109
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppression and circadian function.
Chen-Goodspeed M; Lee CC
J Biol Rhythms; 2007 Aug; 22(4):291-8. PubMed ID: 17660446
[TBL] [Abstract][Full Text] [Related]
3. The role of circadian regulation in cancer.
Gery S; Koeffler HP
Cold Spring Harb Symp Quant Biol; 2007; 72():459-64. PubMed ID: 18419305
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.
Yang X; Wood PA; Oh EY; Du-Quiton J; Ansell CM; Hrushesky WJ
Breast Cancer Res Treat; 2009 Sep; 117(2):423-31. PubMed ID: 18651214
[TBL] [Abstract][Full Text] [Related]
5. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day.
Yang X; Wood PA; Ansell CM; Quiton DF; Oh EY; Du-Quiton J; Hrushesky WJ
Chronobiol Int; 2009 Oct; 26(7):1323-39. PubMed ID: 19916834
[TBL] [Abstract][Full Text] [Related]
6. Clock genes and cancer.
Wood PA; Yang X; Hrushesky WJ
Integr Cancer Ther; 2009 Dec; 8(4):303-8. PubMed ID: 20042409
[TBL] [Abstract][Full Text] [Related]
7. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin.
Oda A; Katayose Y; Yabuuchi S; Yamamoto K; Mizuma M; Shirasou S; Onogawa T; Ohtsuka H; Yoshida H; Hayashi H; Rikiyama T; Kim H; Choe Y; Kim K; Son H; Motoi F; Egawa S; Unno M
Anticancer Res; 2009 Apr; 29(4):1201-9. PubMed ID: 19414365
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer.
Gery S; Komatsu N; Kawamata N; Miller CW; Desmond J; Virk RK; Marchevsky A; Mckenna R; Taguchi H; Koeffler HP
Clin Cancer Res; 2007 Mar; 13(5):1399-404. PubMed ID: 17332281
[TBL] [Abstract][Full Text] [Related]
9. Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy.
Fahrenkrug J; Hannibal J; Georg B
J Neuroendocrinol; 2008 Mar; 20(3):323-9. PubMed ID: 18208549
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of period 1 (PER1) in endometrial carcinoma.
Yeh KT; Yang MY; Liu TC; Chen JC; Chan WL; Lin SF; Chang JG
J Pathol; 2005 May; 206(1):111-20. PubMed ID: 15809976
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes: a possible mechanism of chemotherapy-induced circadian rhythm disturbances.
Terazono H; Hamdan A; Matsunaga N; Hayasaka N; Kaji H; Egawa T; Makino K; Shigeyoshi Y; Koyanagi S; Ohdo S
Biochem Pharmacol; 2008 Apr; 75(8):1616-22. PubMed ID: 18329632
[TBL] [Abstract][Full Text] [Related]
12. Insight into the circadian clock within rat colonic epithelial cells.
Sládek M; Rybová M; Jindráková Z; Zemanová Z; Polidarová L; Mrnka L; O'Neill J; Pácha J; Sumová A
Gastroenterology; 2007 Oct; 133(4):1240-9. PubMed ID: 17675004
[TBL] [Abstract][Full Text] [Related]
13. Circadian time-dependent tumor suppressor function of period genes.
Yang X; Wood PA; Ansell C; Hrushesky WJ
Integr Cancer Ther; 2009 Dec; 8(4):309-16. PubMed ID: 19926612
[TBL] [Abstract][Full Text] [Related]
14. Per3, a circadian gene, is required for Chk2 activation in human cells.
Im JS; Jung BH; Kim SE; Lee KH; Lee JK
FEBS Lett; 2010 Dec; 584(23):4731-4. PubMed ID: 21070773
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.
Chen ST; Choo KB; Hou MF; Yeh KT; Kuo SJ; Chang JG
Carcinogenesis; 2005 Jul; 26(7):1241-6. PubMed ID: 15790588
[TBL] [Abstract][Full Text] [Related]
17. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
18. Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen.
Hoogerwerf WA; Hellmich HL; Cornélissen G; Halberg F; Shahinian VB; Bostwick J; Savidge TC; Cassone VM
Gastroenterology; 2007 Oct; 133(4):1250-60. PubMed ID: 17919497
[TBL] [Abstract][Full Text] [Related]
19. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.
Krugluger W; Brandstaetter A; Kállay E; Schueller J; Krexner E; Kriwanek S; Bonner E; Cross HS
Cancer Res; 2007 Aug; 67(16):7917-22. PubMed ID: 17699798
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppression by the mammalian Period genes.
Lee CC
Cancer Causes Control; 2006 May; 17(4):525-30. PubMed ID: 16596306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
